Skip to main content

No. 19-1434October Term 2019Decided Jul 8, 2021

Docket 19-1434October Term 2019 (2019–2020)

United States v. Arthrex, Inc.

This case could reshape who may make final patent decisions inside the Patent Office and how those officials must be appointed.

Case status

Current stage
Decided
Latest event
Decision released Jul 8, 2021
Case Accepted
Arguments
Decision ReleasedJul 8, 2021
What it's about

This case asked whether administrative patent judges on the Patent Trial and Appeal Board could constitutionally issue final decisions invalidating patents even though they were appointed by the Secretary of Commerce rather than by the President with Senate confirmation. It also raised what the proper remedy should be if that arrangement violated the Constitution’s Appointments Clause.

Question presented

1. Whether, for purposes of the Appointments Clause, U.S. Const. art. II, § 2, cl. 2, administrative patent judges of the U.S. Patent and Trademark Office are principal officers who must be appointed by the President with the Senate’s advice and consent, or “inferior Officers” whose appointment Congress has permissibly vested in a department head. 2. Whether, if administrative patent judges are principal officers, the court of appeals properly cured any Appointments Clause defect in the current statutory scheme prospectively by severing the application of 5 U.S.C. § 7513(a) to those judges.

Case path

United States Court of Appeals for the Federal Circuit / Decision released Jul 8, 2021

Area

Decided Supreme Court case

Briefing

What it's about

The case asks whether administrative patent judges at the Patent Trial and Appeal Board can issue final decisions on patents even though the Secretary of Commerce appoints them. It also asks what fix would be proper if that appointment system breaks the Appointments Clause of the Constitution.

Vote

The case is still pending, and the Court has not scheduled oral argument. The main questions are whether these patent judges are principal officers or inferior officers, and whether the lower court's fix was proper.

Impact

The answer could affect how the Patent Trial and Appeal Board reviews and cancels patents. That matters to inventors, drug companies, and technology firms that rely on patents or challenge them.

What's next

The next sign of movement would be oral argument or another scheduling order from the Court. No decision window is available yet.

What is the core dispute in United States v. Arthrex, Inc.?

The case asks whether Patent Trial and Appeal Board judges were appointed in a constitutional way before issuing final patent decisions.

Why could this case matter outside the courtroom?

If the Court changes the rules, companies and inventors could face new uncertainty about patent challenges and past board decisions.

What should court watchers look for next in this case?

Watch for the Supreme Court to schedule oral argument or issue another order showing how and when the case will move forward.

Decision

Decision record

What the Court decided

This case could reshape who may make final patent decisions inside the Patent Office and how those officials must be appointed.

Impact

The answer could affect how the Patent Trial and Appeal Board reviews and cancels patents. That matters to inventors, drug companies, and technology firms that rely on patents or challenge them.

Not official Court text.

Opinion documents

Timing

Decided July 8, 2021

The Court released its decision on July 8, 2021 without hearing oral argument.